The Changing Prostate Biopsy Landscape
New Methods Needed – The prostate cancer landscape is changing
today—evidenced by younger men being diagnosed, a predominance of lower
stage disease and a growing number of new treatment options. Physicians are looking for new methods to help improve disease staging, select the most appropriate treatment and provide the best long-term patient follow-up.
The Bx Revolution – In view of the changing biopsy landscape, top centers nationwide have established advanced prostate cancer diagnostic programs. With multiple protocols from which to choose—from a standard exam to an 18-core biopsy and beyond—their adoption of Artemis lets them build a baseline of actual biopsy data for each patient.
ROI – Whether you represent an institution needing to study and publish, or run a private practice competing with larger urology centers, the inclusion of Artemis in your practiceprovides the following return on investment:
Precision Targeting
Eliminates prostate deformation for high accuracy of targeted biopsy
- Targeted MR/Ultrasound Biopsy
- 3D Semi Robotic Navigation for Prospective Targeting
- Patient Motion Compensation
- Custom Template Biopsy Plans
- 3D Needle Visualization & Pathology Recording
- Compatible with all U/S systems
- Easy Calibration
- Targeted mpUltrasound Bx
- Electromechanical Probe Stabilization
- Detailed Reporting including Previous Biopsy Cores